Existing weight-loss drugs such as Wegovy, commonly referred to a GLP-1s, mimic the effects of glucagon-like peptide-1, a hormone that regulates metabolism
doi:10.1016/j.xops.2023.100341 31
However, depending on gut microbiota composition, the risk of having an adverse cardiovascular event may be lower in individuals with low versus high circulating TMAO even though choline and/or betaine concentrations in the blood are elevated (115)
GLP-1 medications may cause nausea, injection site reactions, and rare pancreatitis
Trong mt s trng hp, cc chuyn gia c th khuyn ngh tng liu ln 2 vin/ngy, chia thnh hai ln, t hiu qu nhanh hn nhng cn c s t vn ca bc s
Your contribution enables us to continue delivering high-quality, local, and national news coverage